(ESE) ESCO Technologies - Overview

Sector: Technology | Industry: Scientific & Technical Instruments | Exchange: NYSE (USA) | Market Cap: 7.843m USD | Total Return: 25.9% in 12m

Filtration Systems, Diagnostic Equipment, RF Shielding, Naval Components
Total Rating 61
Safety 70
Buy Signal -0.58
Scientific & Technical Instruments
Industry Rotation: -4.2
Market Cap: 7.84B
Avg Turnover: 79.0M
Risk 3d forecast
Volatility31.7%
VaR 5th Pctl5.46%
VaR vs Median4.75%
Reward TTM
Sharpe Ratio1.58
Rel. Str. IBD62.3
Rel. Str. Peer Group61.8
Character TTM
Beta0.867
Beta Downside0.829
Hurst Exponent0.465
Drawdowns 3y
Max DD17.52%
CAGR/Max DD2.61
CAGR/Mean DD8.42
EPS (Earnings per Share) EPS (Earnings per Share) of ESE over the last years for every Quarter: "2021-03": 0.59, "2021-06": 0.67, "2021-09": 0.85, "2021-12": 0.46, "2022-03": 0.65, "2022-06": 0.89, "2022-09": 1.21, "2022-12": 0.6, "2023-03": 0.76, "2023-06": 1.09, "2023-09": 1.25, "2023-12": 0.62, "2024-03": 0.94, "2024-06": 1.16, "2024-09": 1.46, "2024-12": 1.07, "2025-03": 1.35, "2025-06": 1.6, "2025-09": 2.32, "2025-12": 1.64, "2026-03": 1.91,
EPS CAGR: 31.76%
EPS Trend: 96.5%
Last SUE: 0.46
Qual. Beats: 0
Revenue Revenue of ESE over the last years for every Quarter: 2021-03: 165.894, 2021-06: 181.394, 2021-09: 205.478, 2021-12: 177.01, 2022-03: 204.928, 2022-06: 219.066, 2022-09: 256.498, 2022-12: 205.501, 2023-03: 229.136, 2023-06: 248.749, 2023-09: 272.647, 2023-12: 218.314, 2024-03: 249.129, 2024-06: 233.568, 2024-09: 298.533, 2024-12: 214.593, 2025-03: 265.519, 2025-06: 296.344, 2025-09: 352.674, 2025-12: 289.659, 2026-03: 309.341,
Rev. CAGR: 9.97%
Rev. Trend: 91.8%
Last SUE: -0.22
Qual. Beats: 0

Warnings

Below Avwap Earnings

Tailwinds

No distinct edge detected

Description: ESE ESCO Technologies

ESCO Technologies Inc. (ESE) is a diversified manufacturer of highly engineered components and systems serving the aerospace, defense, utility, and RF test and measurement markets. The company’s portfolio includes filtration products, fluid control devices, and mission-critical components for aircraft landing gear and naval signature reduction. Additionally, the firm provides diagnostic testing for the utility sector and RF shielding solutions for research and regulatory compliance applications.

The company operates within the aerospace and defense sector, where high barriers to entry exist due to stringent regulatory certifications and long-term government contracts. ESCO’s business model relies on maintaining specialized technical capabilities to provide sole-source components for long-lifecycle platforms, such as military aircraft and nuclear submarines. For a deeper look into the companys valuation metrics, consider reviewing the detailed analysis available on ValueRay.

Incorporated in 1990 and headquartered in Saint Louis, Missouri, ESCO utilizes a multi-channel distribution strategy involving direct sales teams and third-party representatives. Its Utility Solutions Group specifically focuses on decision-support tools for the renewable energy market, reflecting a strategic pivot toward wind and solar infrastructure monitoring.

Headlines to Watch Out For
  • Commercial aerospace recovery and defense spending drive filtration and landing gear demand
  • U.S. Navy submarine production rates impact signature reduction and power management revenue
  • Diagnostic testing demand for aging utility infrastructure fuels Utility Solutions Group growth
  • Renewable energy expansion increases sales of decision support tools for wind and solar
  • RF Test and Measurement margins depend on global R&D and regulatory compliance spending
Piotroski VR-10 (Strict) 7.5
Net Income: 308.1m TTM > 0 and > 6% of Revenue
FCF/TA: 0.09 > 0.02 and ΔFCF/TA 1.93 > 1.0
NWC/Revenue: 18.14% < 20% (prev 33.46%; Δ -15.32% < -1%)
CFO/TA 0.11 > 3% & CFO 258.9m > Net Income 308.1m
Net Debt (166.1m) to EBITDA (238.7m): 0.70 < 3
Current Ratio: 1.45 > 1.5 & < 3
Outstanding Shares: last quarter (25.9m) vs 12m ago 0.29% < -2%
Gross Margin: 41.88% > 18% (prev 0.41%; Δ 4.15k% > 0.5%)
Asset Turnover: 59.13% > 50% (prev 55.75%; Δ 3.38% > 0%)
Interest Coverage Ratio: 10.45 > 6 (EBITDA TTM 238.7m / Interest Expense TTM 18.3m)
Altman Z'' 4.99
A: 0.09 (Total Current Assets 726.8m - Total Current Liabilities 500.4m) / Total Assets 2.41b
B: 0.60 (Retained Earnings 1.43b / Total Assets 2.41b)
C: 0.09 (EBIT TTM 191.5m / Avg Total Assets 2.11b)
D: 1.73 (Book Value of Equity 1.42b / Total Liabilities 820.4m)
Altman-Z'' = 4.99 = AAA
Beneish M -2.88
DSRI: 0.85 (Receivables 360.4m/343.4m, Revenue 1.25b/1.01b)
GMI: 0.98 (GM 41.88% / 41.25%)
AQI: 1.17 (AQ_t 0.61 / AQ_t-1 0.52)
SGI: 1.23 (Revenue 1.25b / 1.01b)
TATA: 0.02 (NI 308.1m - CFO 258.9m) / TA 2.41b)
Beneish M = -2.88 (Cap -4..+1) = A
What is the price of ESE shares?

As of May 31, 2026, the stock is trading at USD 291.90 with a total of 270,957 shares traded.
Over the past week, the price has changed by +0.58%, over one month by +6.64%, over three months by +11.90% and over the past year by +25.87%.

Is ESE a buy, sell or hold?

ESCO Technologies has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy ESE.

  • StrongBuy: 2
  • Buy: 1
  • Hold: 1
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the ESE price?
Analysts Target Price 373.3 27.9%
ESCO Technologies (ESE) - Fundamental Data Overview as of 30 May 2026
Market Cap USD = 7.84b (7.84b USD * 1.0 USD.USD)
P/E Trailing = 59.4794
P/E Forward = 25.3807
P/S = 6.2847
P/B = 4.9472
P/EG = 1.6685
Revenue TTM = 1.25b USD
EBIT TTM = 191.5m USD
EBITDA TTM = 238.7m USD
Long Term Debt = 125.0m USD (from longTermDebt, last quarter)
Short Term Debt = 27.8m USD (from shortTermDebt, last quarter)
Debt = 258.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 45.7m
Net Debt = 166.1m USD (calculated: Debt 258.4m - CCE 92.3m)
Enterprise Value = 8.01b USD (7.84b + Debt 258.4m - CCE 92.3m)
Interest Coverage Ratio = 10.45 (Ebit TTM 191.5m / Interest Expense TTM 18.3m)
EV/FCF = 37.73x (Enterprise Value 8.01b / FCF TTM 212.3m)
FCF Yield = 2.65% (FCF TTM 212.3m / Enterprise Value 8.01b)
FCF Margin = 17.01% (FCF TTM 212.3m / Revenue TTM 1.25b)
Net Margin = 24.69% (Net Income TTM 308.1m / Revenue TTM 1.25b)
Gross Margin = 41.88% ((Revenue TTM 1.25b - Cost of Revenue TTM 725.4m) / Revenue TTM)
Gross Margin QoQ = 42.45% (prev 41.40%)
Tobins Q-Ratio = 3.33 (Enterprise Value 8.01b / Total Assets 2.41b)
Interest Expense / Debt = 7.09% (Interest Expense 18.3m / Debt 258.4m)
Taxrate = 23.50% (10.3m / 43.9m)
NOPAT = 146.5m (EBIT 191.5m * (1 - 23.50%))
Current Ratio = 1.45 (Total Current Assets 726.8m / Total Current Liabilities 500.4m)
Debt / Equity = 0.16 (Debt 258.4m / totalStockholderEquity, last quarter 1.59b)
Debt / EBITDA = 0.70 (Net Debt 166.1m / EBITDA 238.7m)
Debt / FCF = 0.78 (Net Debt 166.1m / FCF TTM 212.3m)
Total Stockholder Equity = 1.50b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.60% (Net Income 308.1m / Total Assets 2.41b)
RoE = 20.50% (Net Income TTM 308.1m / Total Stockholder Equity 1.50b)
RoCE = 11.76% (EBIT 191.5m / Capital Employed (Equity 1.50b + L.T.Debt 125.0m))
RoIC = 7.58% (NOPAT 146.5m / Invested Capital 1.93b)
WACC = 8.92% (E(7.84b)/V(8.10b) * Re(9.03%) + D(258.4m)/V(8.10b) * Rd(7.09%) * (1-Tc(0.23)))
Discount Rate = 9.03% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 35.96 | Cagr: 0.11%
[DCF] Terminal Value 76.16% ; FCFF base≈177.4m ; Y1≈203.4m ; Y5≈299.3m
[DCF] Fair Price = 151.7 (EV 4.10b - Net Debt 166.1m = Equity 3.93b / Shares 25.9m; r=8.92% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 96.45 | EPS CAGR: 31.76% | SUE: 0.46 | # QB: 0
Revenue Correlation: 91.79 | Revenue CAGR: 9.97% | SUE: -0.22 | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.10 | Chg30d=-0.88% | Revisions=-14% | Analysts=3
EPS current Year (2026-09-30): EPS=8.18 | Chg30d=+0.79% | Revisions=+43% | GrowthEPS=+35.6% | GrowthRev=+20.2%
EPS next Year (2027-09-30): EPS=9.17 | Chg30d=-0.18% | Revisions=+14% | GrowthEPS=+12.2% | GrowthRev=+7.2%
[Analyst] Revisions Ratio: +43%